Stanford’s Dr. Catherine Blish Joins Deepcell’s Advisory Board
Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced that Dr. Catherine Blish, MD, PhD , of Stanford University has joined Deepcells Advisory Board, which is composed of world-renowned experts in biology and life science.
- Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced that Dr. Catherine Blish, MD, PhD , of Stanford University has joined Deepcells Advisory Board, which is composed of world-renowned experts in biology and life science.
- Joining Deepcells Advisory Board provides an opportunity to help the companys leadership team and the scientific community explore the broad uses of Deepcells technology as a tool for new discoveries, interdisciplinary research, and clinically relevant findings.
- Dr. Blish is also a Fellow at the Stanford Center for Innovation in Global Health and an Investigator of the Chan Zuckerberg Biohub.
- I am pleased to welcome Dr. Blish to our Advisory Board, said Maddison Masaeli, co-founder and CEO of Deepcell.